|
Cost-effectiveness of respiratory syncytial virus prophylaxis among preterm infants |
Joffe S, Ray G T, Escobar G J, Black S B, Lieu T A |
|
|
Record Status This is an economic evaluation that meets the criteria for inclusion on NHS EED. Bibliographic details Joffe S, Ray G T, Escobar G J, Black S B, Lieu T A. Cost-effectiveness of respiratory syncytial virus prophylaxis among preterm infants. Pediatrics 1999; 104(3): 419-427 Indexing Status Subject indexing assigned by NLM MeSH Antibodies, Monoclonal /economics /therapeutic use; Antibodies, Monoclonal, Humanized; Cost of Illness; Cost-Benefit Analysis; Decision Support Techniques; Drug Costs /statistics & Hospital Costs /statistics & Hospitalization /economics; Humans; Immunoglobulins, Intravenous /economics /therapeutic use; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases /economics /prevention & Palivizumab; Respiratory Syncytial Virus Infections /economics /prevention & Respiratory Syncytial Viruses; Risk Factors; control; control; numerical data; numerical data AccessionNumber 21999001832 Date bibliographic record published 27/11/1999 |
|
|
|